Large Tornado Hits North Carolina, Hospitalizes Several Interstate 95 Shut Down as Pfizer Facility Suffers Damage Zenger · Jul 20, 2023
Pascal Soriot of AstraZeneca: ‘The climate crisis is a health crisis’ The man who led the drive to create a not-for-profit Covid vaccine is now focusing on the deaths caused by global heating and pollution The Guardian - UK · Jul 18, 2023
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year The Independent UK · Jul 17, 2023
Elderly Nursing Home Residents Denied Life-Saving COVID Treatment, Study Finds Inadequate use of antiviral medication led to avoidable mortality, with Paxlovid underutilized Zenger · Jul 14, 2023
Panadol maker plans sweeping job cuts a year after being spun off from GSK Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally The Guardian - UK · Jul 13, 2023
Should You Buy the Dip in Pfizer Stock? Here's What You Need to Know US stock markets delivered stellar returns in the first half of the year and the Nasdaq 100 had its best first-half performance ever. However, Pfizer, whose COVID-19 vaccine made the company a household name recently fell to a 52-week low. Why is Pfizer stock going down and should you buy… Barchart · Jul 11, 2023
Should Value Investors Watch Pfizer (PFE)? Pfizer (PFE) is spending its COVID-19 cash flows on meaningful growth avenues. However, given a recent downgrade, should value investors still be excited about this stock? Let’s look at the trends of its financial metrics to get an idea…. StockNews.com · Jul 10, 2023
‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest The Guardian - UK · Jul 8, 2023
2 Unusually Active Options to Buy/Sell Not Named Rivian Rivian’s strong sales results drove the unusual options activity in Friday trading. For those who aren’t enamored with the electric vehicle manufacturer’s business, there are, pardon the pun, other options. Barchart · Jul 7, 2023
Health warning as cases of little known disease skyrocket and 'tripledemic' looms Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks Daily Mirror · Jul 6, 2023
AbbVie (ABBV) vs. Pfizer (PFE) - Which Pharma Stock Comes out on Top? With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading…. StockNews.com · Jul 6, 2023
The plan to dodge another tripledemic Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care. Axios · Jul 6, 2023
Up to 10,000 Britons could take part in cancer vaccine trials Participants could receive groundbreaking treatment after the Government signed an agreement with a leading pharmaceutical company. The Independent UK · Jul 5, 2023
A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine. Inverse · Jul 5, 2023
The Guardian - UK · Jul 4, 2023 UK regulator sued for not investigating Covid vaccine ‘misinformation’ Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths
Zenger · Jun 30, 2023 EU Commission Secures Vaccine Production Capacity For Future Crises Pfizer and European pharmaceutical firms to stockpile vaccines for rapid response, raising concerns over equity
Barchart · Jun 29, 2023 Tech Stocks Undercut by Sharp Rise in T-note Yields on Hawkish Powell What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.31%. Stocks are being undercut by today’s hawkish Powell comments,...
Barchart · Jun 29, 2023 Markets Today: Stocks Higher on Positive U.S. Bank Stress Tests Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.23%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.21%. Stocks are higher this morning on U.S. economic resilience as reflected in today’s U.S. economic reports. Also, there is optimism about the U.S. banking system...
The Independent UK · Jun 29, 2023 Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first
The Conversation · Jun 27, 2023 'The dirty disease' – both smokers and non-smokers get lung cancer. They face stigma on top of illness Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting…
The Hindu · Jun 24, 2023 India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24.
Daily Mirror · Jun 19, 2023 Two million Brits have been taking antidepressants for five years or more Brits' long-term dependence on anti-depressants has been laid bare as figures show a quarter of people using the drugs have been taking them for more than five years
The Guardian - AU · Jun 19, 2023 Warren Entsch denies he helped LNP donor get Pfizer vaccine during supply crisis Allegation raised in parliament that MP arranged for property developer Alex Sekler to travel to Torres Strait for Covid jab referred to state corruption watchdog
AAP · Jun 19, 2023 MP denies quid pro quo over COVID-19 jab for donor The federal health minister has accused Liberal MP Warren Enstch of allowing a wealthy donor to use a COVID-19 vaccine dose intended for Indigenous people.
Tribune News Service · Jun 16, 2023 COVID boosters should be updated to target XBB strain, US health advisers say COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.